活性成分市场规模、份额和增长分析（按形式、类型、来源、分布、最终用途行业和地区）- 行业预测，2025-2032 年

2023 年全球活性成分市场规模价值为 2,374.7 亿美元，预计将从 2024 年的 2,510.1 亿美元成长到 2032 年的 3,911 亿美元，预测期内（2025-2032 年）的复合年增长率为 5.7%。

由于消费者对个人美容和化妆品的兴趣日益浓厚、可支配收入不断增加以及都市化加快，个人护理和化妆品市场正在经历显着增长。护肤、护髮和彩妆中对活性成分的需求日益增长，而製药业的进步又促进了创新药物开发，而这些开发需要高品质的活性药物成分 (API)。此外，世界人口快速老化，预计到 2050 年 65 岁及以上人口数量将达到 16 亿，这将推动对与老龄化相关的健康风险相关的有效和安全活性成分的需求。这种人口结构的变化可能会进一步加强个人护理和医疗保健行业的活性成分市场，尤其是在非洲和拉丁美洲等地区。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 原料分析
• 客户和购买标准分析

活性成分市场规模（按形式和复合年增长率） (2025-2032)

• 市场概况
• 固体的
• 液体

活性成分市场规模（按类型和复合年增长率） (2025-2032)

• 市场概况
• 保湿霜
• 抗衰老剂
• UV防晒
• 去角质
• 抗菌剂
• 其他的

活性成分市场规模（按来源和复合年增长率） (2025-2032)

• 市场概况
• 自然的
• 合成

活性成分市场规模（按分布和复合年增长率） (2025-2032)

• 市场概况
• 在线的
• 离线

活性成分市场规模（按最终用途产业和复合年增长率划分）（2025-2032 年）

• 市场概况
• 个人护理及化妆品
  • 头髮护理
  • 护肤
  • 其他的
• 药品
  • 药片
  • 奶油
  • 其他的
• 农业
  • 杀虫剂
  • 除草剂
  • 其他的
• 其他的

活性成分市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Pfizer Inc.（USA）
• Novartis International AG（Switzerland）
• Sanofi SA（France）
• Boehringer Ingelheim GmbH（Germany）
• Bristol-Myers Squibb Company（USA）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Eli Lilly and Company（USA）
• GlaxoSmithKline plc（UK）
• Merck & Co., Inc.（USA）
• AbbVie Inc.（USA）
• Sun Pharmaceutical Industries Ltd.（India）
• Dr. Reddy's Laboratories Ltd.（India）
• Aurobindo Pharma Ltd.（India）
• Cipla Ltd.（India）
• Lupin Limited（India）
• Mylan NV（USA）
• Sandoz International GmbH（Germany）
• Fresenius Kabi AG（Germany）
• Lonza Group AG（Switzerland）

结论和建议

Global Active Ingredients Market size was valued at USD 237.47 billion in 2023 and is poised to grow from USD 251.01 billion in 2024 to USD 391.1 billion by 2032, growing at a CAGR of 5.7% during the forecast period (2025-2032).

The personal care and cosmetics market is experiencing significant growth, driven by rising consumer interest in personal grooming and cosmetics, as well as increasing disposable income and urbanization. This growing demand for active ingredients in skincare, hair care, and color cosmetics is complemented by advancements in the pharmaceutical sector, leading to innovative drug developments that require high-quality active pharmaceutical ingredients (APIs). Additionally, a rapidly aging global population, projected to reach 1.6 billion individuals aged 65 and older by 2050, is expected to heighten the demand for effective and safe active ingredients due to their association with age-related health risks. This demographic shift, particularly in regions like Africa and Latin America, will further bolster the active ingredients market across personal care and healthcare industries.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Active Ingredients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Active Ingredients Market Segmental Analysis

Global Active Ingredients Market is segmented by Form, Type, Source, Distribution, End-Use Industry and region. Based on Form, the market is segmented into Solid and Liquid. Based on Type, the market is segmented into Moisturizing Agents, Anti-ageing Agents, UV Filters, Exfoliating Agents, Antimicrobial Agents and Others. Based on Source, the market is segmented into Natural and Synthetic. Based on Distribution, the market is segmented into Online and Offline. Based on End-Use Industry, the market is segmented into Personal Care & Cosmetics, Pharmaceutical, Agriculture and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Active Ingredients Market

The Global Active Ingredients market is being propelled by a surge in consumer demand for functional nutrients, fueled by heightened awareness of the correlation between nutrition and overall health. As individuals increasingly seek out foods, beverages, and dietary supplements that offer enhanced nutritional value, the emphasis on active ingredients like vitamins, minerals, antioxidants, and plant extracts intensifies. Research into the health benefits of these components-particularly regarding immunity support, mental well-being, and anti-aging properties-further drives this trend. Consequently, the market is witnessing significant growth as consumers prioritize products that contribute to their health and wellness initiatives.

Restraints in the Global Active Ingredients Market

The Global Active Ingredients market faces significant restraints due to price fluctuations in emerging nations. Unpredictable and periodic alterations in drug pricing regulations within these regions, where many manufacturing companies are based, are likely to hinder market expansion during the forecast period. Additionally, the reliance of developed countries on China for the production of active ingredients has led to unexpected changes in China's pricing policies. These fluctuations are anticipated to adversely impact the overall growth of the market, creating challenges for manufacturers and affecting the supply chain dynamics in this sector.

Market Trends of the Global Active Ingredients Market

The Global Active Ingredients market is witnessing a significant trend towards the rising demand for multifunctional active ingredients across various sectors. In pharmaceuticals, these ingredients are increasingly valued for their ability to deliver therapeutic effects alongside enhanced bioavailability and extended release properties. In the personal care and cosmetics realm, consumers prefer products offering comprehensive benefits such as moisture retention, anti-aging effects, and UV protection within a single formulation. Similarly, in agriculture, multifunctional ingredients that combine antimicrobial properties with plant growth promotion enhance crop yield while minimizing application frequency. This trend is propelled by consumer preferences for simplicity and efficiency, cost reductions for manufacturers, and regulatory imperatives to streamline formulations.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Raw Material Analysis
• Customer & Buying Criteria Analysis

Global Active Ingredients Market Size by Form & CAGR (2025-2032)

• Market Overview
• Solid
• Liquid

Global Active Ingredients Market Size by Type & CAGR (2025-2032)

• Market Overview
• Moisturizing Agents
• Anti-ageing Agents
• UV Filters
• Exfoliating Agents
• Antimicrobial Agents
• Others.

Global Active Ingredients Market Size by Source & CAGR (2025-2032)

• Market Overview
• Natural
• Synthetic.

Global Active Ingredients Market Size by Distribution & CAGR (2025-2032)

• Market Overview
• Online
• Offline.

Global Active Ingredients Market Size by End-Use Industry & CAGR (2025-2032)

• Market Overview
• Personal Care & Cosmetics
  • Hair Care
  • Skin Care
  • Others
• Pharmaceutical
  • Tablets
  • Creams
  • Others
• Agriculture
  • Insecticides
  • Herbicides
  • Others
• Others

Global Active Ingredients Market Size & CAGR (2025-2032)

• North America (Form, Type, Source, Distribution, End-Use Industry)
  • US
  • Canada
• Europe (Form, Type, Source, Distribution, End-Use Industry)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Form, Type, Source, Distribution, End-Use Industry)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Form, Type, Source, Distribution, End-Use Industry)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Form, Type, Source, Distribution, End-Use Industry)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis International AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sandoz International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations